Ameriprise’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History

Ameriprise’s Portfolio RNA Stock Details RNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-16,099	Closed	-$302K	–	4005
2014 Q4	$302K	Buy	+16,099	New	+$229K	﹤0.01%	3331
2014 Q1	–	Sell	-18,200	Closed	-$85K	–	5505
2013 Q4	$85K	Sell	18,200 -338,828	-95%	-$1.54M	﹤0.01%	3448
2013 Q3	$2.36M	Buy	+357,028	New	+$8.39M	﹤0.01%	2359

Ameriprise's RNA Position: Q1 2015 in Review

Ameriprise sold out of PROSENSA HLDGS N V ORD SHS (NLD) (RNA) in Q1 2015, closing a stake of 16,099 shares — an estimated $302K sold.

Ameriprise first reported a position in RNA in Q3 2013 and held it in 3 quarters. The position peaked at $2.36M in Q3 2013. 0 funds tracked by Wall St. Rank hold RNA as of Q1 2015.

Ameriprise reported no remaining PROSENSA HLDGS N V ORD SHS (NLD) position as of Q1 2015 after selling out during the quarter.
Ameriprise sold 16,099 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q1 2015, an estimated $302K.
Ameriprise first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q3 2013 and held it in 3 quarters.
Ameriprise's PROSENSA HLDGS N V ORD SHS (NLD) position peaked at $2.36M in Q3 2013.
0 funds tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q1 2015.

Based on Ameriprise's 13F filing for Q1 2015, filed 14 May 2015.